Barbo William D
Known title: Corporate Executive VP & CCOCIK: 0001688104
Associated companies
Transaction History
| CRL | ▼ Sell | Gift | 470 | $0 | 11/7/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 179 | $38K | 5/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 84 | $18K | 5/28/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 132 | $29K | 5/27/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 177 | $38K | 5/26/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 4,050 | $1.0M | 2/22/2024 | View on chart |
| CRL | ▲ Buy | Grant | 2,997 | $0 | 1/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 770 | $170K | 1/29/2024 | View on chart |
| CRL | ▲ Buy | Option Exercise | 5,511 | $797K | 8/10/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 5,763 | $1.3M | 8/10/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 202 | $39K | 5/29/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 112 | $22K | 5/28/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 166 | $32K | 5/27/2023 | View on chart |
| CRL | ▲ Buy | Grant | 1,958 | $0 | 5/26/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 287 | $70K | 2/22/2023 | View on chart |
| CRL | ▲ Buy | Grant | 7,857 | $0 | 1/27/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 2,897 | $708K | 1/27/2023 | View on chart |
| CRL | ▲ Buy | Option Exercise | 3,205 | $350K | 12/2/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 406 | $89K | 12/2/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 873 | $192K | 12/2/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 1,226 | $270K | 12/2/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 700 | $155K | 12/2/2022 | View on chart |
| CRL | ▼ Sell | Gift | 200 | $0 | 11/15/2022 | View on chart |
| CRL | ▼ Sell | Gift | 391 | $0 | 6/7/2022 | View on chart |
| CRL | ▼ Sell | Gift | 391 | $0 | 6/7/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 202 | $49K | 5/29/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 112 | $27K | 5/28/2022 | View on chart |
| CRL | ▲ Buy | Grant | 1,493 | $0 | 5/27/2022 | View on chart |
| CRL | ▼ Sell | Gift | 754 | $0 | 3/11/2022 | View on chart |
| CRL | ▼ Sell | Gift | 754 | $0 | 3/11/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 315 | $91K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 287 | $84K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Gift | 6,178 | $0 | 2/8/2022 | View on chart |
| CRL | ▼ Sell | Gift | 6,178 | $0 | 2/8/2022 | View on chart |
| CRL | ▲ Buy | Grant | 10,273 | $0 | 1/28/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 4,095 | $1.3M | 1/28/2022 | View on chart |
| CRL | ▼ Sell | Gift | 400 | $0 | 12/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage
Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.